This article, published by Consulting.ca, discusses results from Buck’s 2019 Canadian Health Trend Survey, which showed that insurance providers’ pharmaceutical trend factor increases were significantly higher than increases in actual drug costs.
Related insights
Podcast: Talking tomorrow, today
Launched in January 2021, this podcast series delves into a range of topical issues...
En savoir plusWebinar: Getting COVID-19 Shots in Employee Arms
Join our speakers to learn: How your organization can prepare for the vaccine rollout...
En savoir plusCase study: Specialty Drug Claim Review
Concerned about spiraling specialty drug costs, a major pharmaceutical company asked Buck’s Pharmacy team to...
En savoir plus